- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ ↓ -0.04%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 11 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth | 14.37% | -0.04% | -0.66% | -1.43% | 7.56% | 19.24% | 18.81% | 13.52% | - | - |
| SBI NIFTY INDEX FUND - DIRECT PLAN - GROWTH | -9.82% | -0.34% | -2.09% | -4.37% | 1.56% | -5.65% | 6.34% | 7.13% | 12.21% | 11.1% |
| SBI Nifty Next 50 Index Fund - Direct Plan - Growth | 4.05% | -0.62% | -1.1% | -3.39% | 5.76% | 6.66% | 16.21% | 11.58% | - | - |
| SBI CPSE Bond Plus SDL Sep 2026 50:50 Index Fund - Direct Plan - Growth | 4.13% | 0.01% | 0.09% | 0.47% | 1.49% | 6.02% | 7.24% | - | - | - |
| SBI CRISIL IBX Gilt Index - April 2029 Fund - Direct Plan - Growth | 3.11% | -0.12% | -0.11% | -0.04% | 1.16% | 5.3% | 7.7% | - | - | - |
| SBI |CRISIL IBX Gilt Index - June 2036 Fund - Direct Plan - Growth | 2.69% | -0.38% | -0.35% | -0.96% | 1.09% | 4.29% | 7.49% | - | - | - |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 3.83% | -0.71% | -2.51% | 5.16% | -4.55% | 2.98% | 2.43% | 7.08% | 4.05% | 2.49% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.82% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.18% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.30% | |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.07% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.69% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.89% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.69% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.61% | |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.02% | |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 3.63% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.48% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.93% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.61% | |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.99% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.74% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.61% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.54% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.52% | |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.32% | |
| Aster DM Quality Care Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 1.21% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.17% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.96% | |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.78% | |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.71% | |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.64% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.44% | |
| ELI LILLY & CO | (US5324571083) | Pharmaceuticals | 6.43% | |
| JOHNSON & JOHNSON | (US4781601046) | Pharmaceuticals | 4.30% | |
| ABBVIE INC | (US00287Y1091) | Biotechnology | 3.09% | |
| MERCK & CO.INC | (US58933Y1055) | Pharmaceuticals | 2.24% | |
| NOVARTIS AG | (US66987V1098) | Pharmaceuticals | 1.99% | |
| THERMO FISHER SCIENTIFIC INC | (US8835561023) | Life Sciences Tools & Services | 1.49% | |
| AMGEN INC | (US0311621009) | Biotechnology | 1.45% | |
| ABBOTT LABORATORIES | (US0028241000) | Health Care Equipment & Supplies | 1.28% | |
| GILEAD SCIENCES INC | (US3755581036) | Biotechnology | 1.13% | |
| Novo Nordisk A/S | (US6701002056) | Pharmaceuticals & Biotechnology | 1.06% | |
| INTUITIVE SURGICAL INC | (US46120E6023) | Health Care Equipment & Supplies | 0.87% | |
| DANAHER CORP | (US2358511028) | Health Care Equipment & Supplies | 0.87% | |
| VERTEX PHARMACEUTICALS INC | (US92532F1003) | Biotechnology | 0.84% | |
| STRYKER CORP | (US8636671013) | Health Care Equipment & Supplies | 0.78% | |
| MEDTRONIC PLC | (IE00BTN1Y115) | Health Care Equipment & Supplies | 0.76% | |
| Regeneron Pharmaceuticals Inc | (US75886F1075) | Pharmaceuticals | 0.55% | |
| BECTON DICKINSON AND CO | (US0758871091) | Health Care Equipment & Supplies | 0.33% | |
| IQVIA HOLDINGS INC | (US46266C1053) | Life Sciences Tools & Services | 0.28% | |
| AGILENT TECHNOLOGIES INC | (US00846U1016) | Life Sciences Tools & Services | 0.27% | |
| WATERS CORP | (US9418481035) | Pharmaceuticals | 0.26% |
Portfolio data is as on date 31 July, 2026
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 11 September, 2026 | 24.512 | -0.04% |
| 10 September, 2026 | 24.5229 | -0.43% |
| 9 September, 2026 | 24.6283 | -0.02% |
| 8 September, 2026 | 24.6337 | -0.17% |
| 4 September, 2026 | 24.6758 | -0.9% |
| 3 September, 2026 | 24.8992 | -0.33% |
| 2 September, 2026 | 24.9817 | 0.15% |
| 1 September, 2026 | 24.9452 | -1.02% |
| 31 August, 2026 | 25.2035 | 0.33% |
| 28 August, 2026 | 25.1209 | 0.28% |
| 27 August, 2026 | 25.0514 | 0% |
| 26 August, 2026 | 25.0524 | -0.45% |
| 25 August, 2026 | 25.1655 | 0.87% |
| 24 August, 2026 | 24.9474 | -0.11% |
| 21 August, 2026 | 24.9759 | 0.25% |
| 20 August, 2026 | 24.9134 | -0.55% |
| 19 August, 2026 | 25.0509 | 1.03% |
| 18 August, 2026 | 24.7954 | 0.82% |
| 17 August, 2026 | 24.594 | -0.17% |
| 14 August, 2026 | 24.635 | -0.49% |
| 13 August, 2026 | 24.7574 | -0.1% |
| 12 August, 2026 | 24.7829 | -0.34% |
| 11 August, 2026 | 24.8672 | 0.26% |
| 10 August, 2026 | 24.8021 | 0.41% |
| 7 August, 2026 | 24.7019 | 0.37% |
| 6 August, 2026 | 24.6098 | 0.17% |
| 5 August, 2026 | 24.5691 | 0.27% |
| 4 August, 2026 | 24.503 | -0.21% |
| 3 August, 2026 | 24.5534 | -0.15% |
| 31 July, 2026 | 24.5908 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 24.512 as on 11 September, 2026.What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 14.37% as on 11 September, 2026.What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 19.24% as on 11 September, 2026.What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 18.81% as on 11 September, 2026.What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 13.52% as on 11 September, 2026.